Category: Merkel cell carcinoma

Home / Merkel cell carcinoma

Categories

Retifanlimab-dlwr is approved by FDA for metastatic or recurrent locally advanced Merkel cell carcinoma

April 2023: Retifanlimab-dlwr (Zynyz, Incyte Corporation) received fast approval from the Food and Drug Administration to treat adult patients with metastatic or recurrent locally advanced Merkel cel...

We Are Online! Chat With Us!
Scan the code